MedTrace Logo

Does Low-does Cervical Epidural Lidocaine Cause Transient Weakness?

NCT03382925 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2022-11-25

Study results available
· View outcomes & findings →

Summary

"Does low-does cervical epidural lidocaine cause transient weakness?"

Conditions

  • Cervical Radiculopathy

Interventions

PROCEDURE

cervical interlaminar with lidocaine

Interlaminar cervical epidural steroid injection at the C7-T1 level with triamcinolone 80 mg (40 mg/mL) + 2 mL 1% lidocaine.

PROCEDURE

cervical interlaminar with normal saline

Interlaminar cervical epidural steroid injection at the C7-T1 level with triamcinolone 80 mg (40 mg/mL) + 2 mL preservative saline

DRUG

Lidocaine

2 mL lidocaine to be used as steroid diluent in group #1 cervical interlaminar procedure.

DRUG

Triamcinolone Acetonide

2 mL of 40 mg/mL will be used as the steroid in group #1 and group #2 cervical interlaminar procedures.

DRUG

Normal saline

2 mL of normal saline to be used as steroid diluent in group #2 cervical interlaminar procedure.

Sponsors & Collaborators

Principal Investigators

  • Zachary L McCormick, MD · University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-20
Primary Completion
2019-08-19
Completion
2020-08-19
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03382925 on ClinicalTrials.gov